Last reviewed · How we verify
NCT03986918
Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System
trial testing Routine Total Hip Arthroplasty in Joint Diseases in 400 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | Ortho Development Corporation |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 June 2019 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Routine Total Hip Arthroplasty
Conditions studied
- Joint Diseases — all drugs for Joint Diseases →
- Osteoarthritis, Hip — all drugs for Osteoarthritis, Hip →
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Psoriatic Arthritis — all drugs for Psoriatic Arthritis →
Sponsor
Ortho Development Corporation
Who can join
Adults 18 to 80, any sex, with Joint Diseases or Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate patient outcomes in regards to safety and effectiveness based on the clinical performance of the reference devices to further support the assessment of residual risk identified in the Clinical Evaluation Report for the Ortho Development Hip System.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03986918
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Joint Diseases
Currently open trials in the same condition.
- NCT07391592 — Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate · active not recruiting
- NCT06404346 — Comparative Effectiveness of HVT and Bowen Technique in Patients of SI Joint Dysfunction With Upslipped Innominates · NA · active not recruiting
- NCT05844124 — Impact of Different Exercise Programs on Knee OA · NA · active not recruiting
- NCT04536103 — Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry · recruiting
- NCT04328181 — Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomo · NA · recruiting
Other Ortho Development Corporation trials
Trials by the same sponsor.
- NCT04277416 — Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03986918 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ortho Development Corporation
- Last refreshed: 14 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03986918.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing